Improving risk factor modification: A global approach

Current Cardiology Reports

Volumn 11, Issue 6, 2009, Pages 476-483

  Borden, William B ^a   Muchiteni, Tshaka ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINE GUM; NICOTINE PATCH; THIAZIDE DIURETIC AGENT; VARENICLINE;

BODY MASS; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET; DIET THERAPY; HEALTH CARE QUALITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; MENTAL DISEASE; NICOTINE REPLACEMENT THERAPY; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SMOKING; SMOKING CESSATION; SOCIAL PSYCHOLOGY; TOBACCO DEPENDENCE;

DIABETES COMPLICATIONS; DIET; EXERCISE; HEART DISEASES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LIFE STYLE; MOTOR ACTIVITY; NUTRITIONAL STATUS; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SMOKING; UNITED STATES;

EID: 72849129178     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-009-0068-y     Document Type: Review

References (50)

1. E.S. Ford U.A. Ajani J.B. Croft, et al. 2007 Explaining the decrease in U.S. deaths from coronary disease, 1980-2000 N Engl J Med 356 2388 2398 10.1056/NEJMsa053935 1:CAS:528:DC%2BD2sXmt1Wnsbs%3D 17554120 (Pubitemid 46883773)
2. D. Forman B.E. Bulwer 2006 Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle Curr Treat Options Cardiovasc Med 8 47 57 10.1007/s11936-006-0025-7 16401383
3. M. Sidani C. Ziegler 2008 Preventing Heart disease: who needs to be concerned and what to do Prim Care 35 589 607 18928820
4. D.M. Lloyd-Jones E.P. Leip M.G. Larson, et al. 2006 Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 791 798 10.1161/CIRCULATIONAHA.105.548206 16461820 (Pubitemid 43754299)
5. D. Wood G. De Backer O. Faergeman, et al. 1998 Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention Atherosclerosis 140 199 270 10.1016/S0021-9150(98)90209-X 1:CAS:528: DyaK1cXnslGitrw%3D 9862269 (Pubitemid 28535317)
6. D. Lloyd-Jones R. Adams M. Carnethon, et al. 2009 Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 480 486 10.1161/CIRCULATIONAHA.108.191259 19171871
7. J. Stamler R. Stamler J.D. Neaton, et al. 1999 Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women JAMA 282 2012 2018 10.1001/jama.282.21.2012 1:STN:280: DC%2BD3c%2Flslensg%3D%3D 10591383
8. M.L. Daviglus K. Liu P. Greenland, et al. 1998 Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs N Engl J Med 339 1122 1129 10.1056/NEJM199810153391606 1:STN:280: DyaK1cvjt1CmsQ%3D%3D 9770560 (Pubitemid 28465761)
9. P.W. Wilson R.B. D'Agostino D. Levy, et al. 1998 Prediction of coronary heart disease using risk factor categories Circulation 97 1837 1847 1:STN:280:DyaK1c3msVOjsA%3D%3D 9603539
10. S.M. Grundy G.J. Balady M.H. Criqui, et al. 1998 Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association Circulation 97 1876 1887 1:STN:280:DyaK1c3msVOisA%3D%3D 9603549
11. Framingham Heart Study: History of the Framingham Heart Study. Available at http://www.framinghamheartstudy.org/about/history.html. Accessed August 2009.
12. P.M. Ridker J.E. Buring N. Rifai N.R. Cook 2007 Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 611 619 10.1001/jama.297.6.611 1:CAS:528:DC%2BD2sXhslCqtLk%3D 17299196 (Pubitemid 46257283)
13. P.M. Ridker N.P. Paynter N. Rifai, et al. 2008 C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2243 2251 10.1161/CIRCULATIONAHA.108.814251 1:CAS:528:DC%2BD1cXhtlyks7bE 18997194
14. H.W. Hense E. Koesters J. Wellmann, et al. 2008 Evaluation of a recalibrated Systematic Coronary Risk Evaluation cardiovascular risk chart: results from Systematic Coronary Risk Evaluation Germany Eur J Cardiovasc Prev Rehabil 15 409 415 10.1097/HJR.0b013e3282feec66 18677164
15. S.L. Cobb D.J. Brown L.L. Davis 2006 Effective interventions for lifestyle change after myocardial infarction or coronary artery revascularization J Am Acad Nurse Pract 18 31 39 10.1111/j.1745-7599.2006.00096. x 16403210
16. J. N. Castaldo T. Wasser T. Masiado, et al. 2005 Physician attitudes regarding cardiovascular risk reduction: the gaps between clinical importance, knowledge, and effectiveness Dis Manag 8 93 105 10.1089/dis.2005.8.93 15815158 (Pubitemid 40586382)
17. M. de Lorgeril P. Salen J.L. Martin, et al. 1999 Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study Circulation 99 779 785 9989963
18. L.J. Appel T.J. Moore E. Obarzanek, et al. 1997 A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group N Engl J Med 336 1117 1124 10.1056/NEJM199704173361601 1:STN:280: DyaK2s3jvVOmsA%3D%3D 9099655 (Pubitemid 27374693)
19. T.A. Pearson S.N. Blair S.R. Daniels, et al. 2002 AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee Circulation 106 388 391 10.1161/01.CIR. 0000020190.45892.75 12119259 (Pubitemid 34778969)
20. B.V. Howard L. Van Horn J. Hsia, et al. 2006 Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial JAMA 295 655 666 10.1001/jama.295.6.655 1:CAS:528:DC%2BD28XhtF2rsrY%3D 16467234 (Pubitemid 43209067)
21. R.J. de Souza J.F. Swain L.J. Appel F.M. Sacks 2008 Alternatives for macronutrient intake and chronic disease: a comparison of the OmniHeart diets with popular diets and with dietary recommendations Am J Clin Nutr 88 1 11 18614716
22. C. Walker B.V. Reamy 2009 Diets for cardiovascular disease prevention: what is the evidence? Am Fam Physician 79 571 578 19378874
23. P.H. Lin L.J. Appel K. Funk, et al. 2007 The PREMIER intervention helps participants follow the Dietary Approaches to Stop Hypertension dietary pattern and the current Dietary Reference Intakes recommendations J Am Diet Assoc 107 1541 1551 10.1016/j.jada.2007.06.019 1:CAS:528:DC%2BD2sXhtFGks7rF 17761231 (Pubitemid 47304472)
24. A.C. King W.L. Haskell D.R. Young, et al. 1995 Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years Circulation 91 2596 2604 1:CAS:528:DyaK2MXms12nsr4%3D 7743622
25. P. Kokkinos J. Myers E. Nylen, et al. 2009 Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes Diabetes Care 32 623 628 10.2337/dc08-1876 19196898
26. I. Lowensteyn L. Coupal H. Zowall S.A. Grover 2000 The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular disease J Cardiopulm Rehabil 20 147 155 10.1097/00008483-200005000-00002 1:STN:280:DC%2BD3M%2FjvF2jtA%3D%3D 10860196
27. P. Kokkinos A. Manolis A. Pittaras, et al. 2009 Exercise capacity and mortality in hypertensive men with and without additional risk factors Hypertension 53 494 499 10.1161/HYPERTENSIONAHA.108.127027 1:CAS:528: DC%2BD1MXhs1CntLY%3D 19171789
28. C.A. Slentz B.D. Duscha J.L. Johnson, et al. 2004 Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE-a randomized controlled study Arch Intern Med 164 31 39 10.1001/archinte.164.1.31 14718319 (Pubitemid 38067386)
29. W.L. Haskell I.M. Lee R.R. Pate, et al. 2007 Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association Circulation 116 1081 1093 10.1161/CIRCULATIONAHA.107.185649 17671237 (Pubitemid 47329572)
30. D. Ornish L.W. Scherwitz J.H. Billings, et al. 1998 Intensive lifestyle changes for reversal of coronary heart disease JAMA 280 2001 2007 10.1001/jama.280.23.2001 1:STN:280:DyaK1M%2FnvFGmtw%3D%3D 9863851
31. S.C. Smith Jr J. Allen S.N. Blair, et al. 2006 AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute Circulation 113 2363 2372 10.1161/CIRCULATIONAHA.106.174516 16702489 (Pubitemid 43947981)
32. V. Lemmens A. Oenema I.K. Knut J. Brug 2008 Effectiveness of smoking cessation interventions among adults: a systematic review of reviews Eur J Cancer Prev 17 535 544 10.1097/CEJ.0b013e3282f75e48 18941375
33. S.M. Mohiuddin A.N. Mooss C.B. Hunter, et al. 2007 Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease Chest 131 446 452 10.1378/chest.06-1587 17296646 (Pubitemid 46280405)
34. R.L. Murray L. Bauld L.E. Hackshaw A. McNeill 2009 Improving access to smoking cessation services for disadvantaged groups: a systematic review J Public Health (Oxf) 31 258 277 10.1093/pubmed/fdp008
35. L. Erhardt 2009 Cigarette smoking: an undertreated risk factor for cardiovascular disease Atherosclerosis 205 23 32 10.1016/j.atherosclerosis.2009. 01.007 1:CAS:528:DC%2BD1MXnsFagtb4%3D 19217623
36. A.V. Chobanian G.L. Bakris H.R. Black, et al. 2003 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2560 2572 10.1001/jama.289.19.2560 1:CAS:528:DC%2BD3sXjvFCqtrk%3D 12748199 (Pubitemid 37430158)
37. E. Dembowski M.H. Davidson 2009 A review of lipid management in primary and secondary prevention J Cardiopulm Rehabil Prev 29 2 12 19158581
38. C. Baigent A. Keech P.M. Kearney, et al. 2005 Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 1267 1278 10.1016/S0140-6736(05)67394-1 1:CAS:528:DC%2BD2MXhtVOlu7fM 16214597 (Pubitemid 41416582)
39. L.A. Smaha 2004 The American Heart Association Get With The Guidelines program Am Heart J 148 5Suppl S46 S48 10.1016/j.ahj.2004.09.015 15514634
40. A.T. Yan R.T. Yan M. Tan, et al. 2006 Contemporary management of dyslipidemia in high-risk patients: targets still not met Am J Med 119 676 683 10.1016/j.amjmed.2005.11.015 16887414 (Pubitemid 44128440)
41. R.M. Califf E.R. DeLong T. Ostbye, et al. 2002 Underuse of aspirin in a referral population with documented coronary artery disease Am J Cardiol 89 653 661 10.1016/S0002-9149(01)02335-9 11897205 (Pubitemid 34230559)
42. R. Shrivastava A. Khan V. Jeevanantham, et al. 2008 Control of cardiovascular risk factors and use of aspirin in diabetic patients remain elusive South Med J 101 606 611 18475221
43. R.H. Mehta C.K. Montoye M. Gallogly, et al. 2002 Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative JAMA 287 1269 1276 10.1001/jama.287.10.1269 11886318
44. D.M. Elston 2008 The physician quality reporting initiative Clin Lab Med 28 351 357 10.1016/j.cll.2007.12.012 18436076 (Pubitemid 351626239)
45. J. Stulberg 2008 The physician quality reporting initiative-a gateway to pay for performance: what every health care professional should know Qual Manag Health Care 17 2 8 18204372
46. Mackenzie K: What Obama Means for Health Information Technology. Available at http://www.healthleadersmedia.com/content/223238/topic/WS-HLM2-TEC/ What-Obama-Means-for-Health-Information-Technology.html. Accessed August 2009.
47. K. Berra J. Ma L. Klieman, et al. 2007 Implementing cardiac risk-factor case management: lessons learned in a county health system Crit Pathw Cardiol 6 173 179 18091408
48. K. Orth-Gomér 2007 Psychosocial and behavioral aspects of cardiovascular disease prevention in men and women Curr Opin Psychiatry 20 147 151 10.1097/YCO.0b013e32802b705e 17278913 (Pubitemid 46215422)
49. A. Rozanski J.A. Blumenthal K.W. Davidson, et al. 2005 The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology J Am Coll Cardiol 45 637 651 10.1016/j.jacc.2004.12.005 15734605 (Pubitemid 40278960)
50. P.C. Strike A. Steptoe 2004 Psychosocial factors in the development of coronary artery disease Prog Cardiovasc Dis 46 337 347 10.1016/j.pcad.2003.09. 001 14961456 (Pubitemid 38201295)